The best element of Foley’s swift action is Daxi sales for Q3 will reflect the additional sales from the new lower pricing! Q4 will be a killer quarter as the big MedSpa practices adopt Daxi and RHA into their practices. Both Daxi and RHA sales should grow quickly!
Allergan can NOT lower their price for cosmetic Botox which would cost Allergan millions with the lower therapeutic price…therapeutic is a % of the average cosmetic price which includes any free products but not staff trading.
Allergan gives doctors staff training Botox and Juvederm as a way to lower the price of products! The doctors have to sign saying they will not sell the product. This is Allergan’s way of covering their butt and now if the doctor sells the staff training product, it is the doctor who is legally responsible! The doctors should stand up to Allergan and stop taking responsibility…make Allergan give them FREE products which they can legally sell. Allergan will not do this, because all free products are charged against their calculations for the therapeutic price. This is how Allergan is cheating the federal government and keeping their therapeutic price higher.
On another topic, CD sales will start very soon or the therapeutic division will be sold.
Any way you cut this RVNC pie, it is all good! Hopefully, on investor day, Foley will provide a Q3 cosmetic sales forecast update which could run the stock up. The short squeeze will happen soon! Just a matter of days. I am sure the shorts are getting nervous!
News 
Market Data 
Discover 
